Publications
268
Citations
17,847
Est. group size
—
Recurring co-author estimate
Active years
36
Publishing since 1991
This researcher works in immunology and neurology, with recent work spanning multiple sclerosis, immune responses to vaccines and viral infections, and blood-based biomarkers for detecting Alzheimer's disease. A notable focus is developing and validating laboratory tests (such as plasma amyloid and p-tau measurements) that could help diagnose Alzheimer's disease earlier and more affordably, alongside studies on immune cell behavior in autoimmune and infectious disease contexts. This body of work suggests interests bridging clinical neurology, immunology, and diagnostic biomarker development.
Publication output has been fairly steady over the last decade, with some fluctuation year to year but a slight uptick in the early 2020s followed by continued consistent output through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Cost-effectiveness analysis of blood-based biomarker testing in the diagnosis of Alzheimer’s disease pathology
The Journal of Prevention of Alzheimer s Disease · 2026
- ImmuSeeker: deep mining of immune-related gene family signatures through lineage reconstruction
Genome biology · 2026
- K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity
Journal of Biomedical Science · 2025
- Development and Clinical Validation of Blood-Based Multibiomarker Models for the Evaluation of Brain Amyloid Pathology
Neurology Clinical Practice · 2025
- Development and clinical validation of blood-based multibiomarker models for the evaluation of brain amyloid pathology
medRxiv · 2025
- Combination of Plasma Beta Amyloid 42/40 and P-tau217 in the Assessment of Alzheimer’s Disease (S15.004)
Neurology · 2025
- Correction: K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity
Journal of Biomedical Science · 2025
- Evaluation of a Novel Home‐Based Pathway to Support Early Detection and Diagnosis of Alzheimer's Disease
Alzheimer s & Dementia · 2025
- Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment
Frontiers in Neurology · 2024
- The AlzMatch Pilot Study - Feasibility of Remote Blood Collection of Plasma Biomarkers for Preclinical Alzheimer's Disease Trials
The Journal of Prevention of Alzheimer s Disease · 2024
- New plasma LC-MS/MS assays for the quantitation of beta-amyloid peptides and identification of apolipoprotein E proteoforms for Alzheimer’s disease risk assessment
Journal of Investigative Medicine · 2024
- IL-1 receptor 1 signaling shapes the development of viral antigen-specific CD4+ T cell responses following COVID-19 mRNA vaccination
EBioMedicine · 2024
- Machine Learning Analysis Using RNA Sequencing to Distinguish Neuromyelitis Optica from Multiple Sclerosis and Identify Therapeutic Candidates
Journal of Molecular Diagnostics · 2024
- Incidence of Pediatric Autoimmune Encephalitis Reported from a National Laboratory (P5-14.012)
Neurology · 2024
- Self-reported longitudinal COVID-19 vaccination reactogenicity profiles in persons with multiple sclerosis
Multiple Sclerosis and Related Disorders · 2024
- Neurology×10
- Journal of Neuroimmunology×7
- Alzheimer s & Dementia×4
- Multiple Sclerosis and Related Disorders×3
- JCI Insight×3
- Benjamin M. Segal
Medicine · The Ohio State University
- Qiuming Zeng
Medicine · The Ohio State University
- Yuji Tomizawa
Medicine · The Ohio State University
- Tirisham Gyang
Medicine · The Ohio State University
- Amy E. Lovett‐Racke
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile